The Valley Desk

NCT05254990 · Interventional trial

Reparixin add-on Therapy to Standard Care to Limit Progression in Pts With COVID19 & Other Community Acquired Pneumonia

Overall registry status Terminated

Phase 3

Conditions Infectious Pneumonia, Severe COVID-19

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov